MG
TWST icon

Mather Group’s Twist Bioscience TWST Stock Holding History

Mather Group’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2
Closed -$95 – 1976
2026
Q1 		$95 Buy
+2
New +$90 ﹤0.01% 1869
2024
Q3 		– Sell
-38
Closed -$1.3K – 2184
2024
Q2 		$1.3K Buy
+38
New +$1.55K ﹤0.01% 1966

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Mather Group's TWST Position: Q2 2026 in Review

Mather Group sold out of Twist Bioscience (TWST) in Q2 2026, closing a stake of 2 shares — an estimated $95 sold.

Mather Group first reported a position in TWST in Q2 2024 and held it in 2 quarters. The position peaked at $1.3K in Q2 2024. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Mather Group reported no remaining Twist Bioscience position as of Q2 2026 after selling out during the quarter.
  • Mather Group sold 2 Twist Bioscience shares in Q2 2026, an estimated $95.
  • Mather Group first reported a position in Twist Bioscience in Q2 2024 and held it in 2 quarters.
  • Mather Group's Twist Bioscience position peaked at $1.3K in Q2 2024.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.